Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 1 3Phase EARLY_PHASE1 1Phase 3 1Phase 1/2 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Neoplasms 3Colorectal Neoplasms 3Colonic Neoplasms 3Uterine Cervical Dysplasia 1Stomatitis 1Rectal Neoplasms 1Pain 1Neurofibromatosis 1 1Lung Neoplasms 1Castration Sensitive Prostate Cancer 1Breast Neoplasms 1Advanced Cancers 1

Interventions

Oxaliplatin 31Fluorouracil 31Leucovorin 29Irinotecan 23Cetuximab 20Bevacizumab 16Capecitabine 13Gemcitabine 11pembrolizumab 8Folfox protocol 7Cisplatin 7Carboplatin 7Paclitaxel 6Nivolumab 6Cyclophosphamide 6trifluridine tipiracil drug combination 5cediranib 5Erlotinib Hydrochloride 5adagrasib 4Ipilimumab 4IFL protocol 4Floxuridine 4Bortezomib 4veliparib 3trametinib 3sargramostim 3poly ICLC 3binimetinib 3Trifluridine 3Sorafenib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Colonic Neoplasms × Curcumin × Clear all
NCT01859858 2023-12-04

Effect of Curcumin on Dose Limiting Toxicity and Pharmacokinetics of Irinotecan in Patients With Solid Tumors

UNC Lineberger Comprehensive Cancer Center

Phase 1 Completed
23 enrolled
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT00973869 2014-06-24

Curcumin in Preventing Colorectal Cancer in Patients Undergoing Colorectal Endoscopy or Colorectal Surgery

National Cancer Institute (NCI)

Phase 1 Unknown
30 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00027495 2012-12-21

Curcumin for the Prevention of Colon Cancer

University of Michigan Rogel Cancer Center

Phase 1 Completed
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡